BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15601856)

  • 1. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.
    Hiratsuka S; Kataoka Y; Nakao K; Nakamura K; Morikawa S; Tanaka S; Katsuki M; Maru Y; Shibuya M
    Mol Cell Biol; 2005 Jan; 25(1):355-63. PubMed ID: 15601856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
    Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M
    Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G; Clauss M; Risau W
    Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse.
    Nalbandian A; Dettin L; Dym M; Ravindranath N
    Biol Reprod; 2003 Sep; 69(3):985-94. PubMed ID: 12773425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
    Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
    Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
    Kremer C; Breier G; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Altered expression of vascular endothelial growth factor and its receptors in transdifferentiated human proximal tubular epithelial cells induced by transforming growth factor beta1].
    Zhou QG; Zheng FL; Wen YB; Tan XY; Duan L; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):325-31. PubMed ID: 16038269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2.
    Abbott BD; Buckalew AR
    Dev Dyn; 2000 Dec; 219(4):526-38. PubMed ID: 11084652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.